Publications While At Healthpartners
Clinical-genetic associations in the Prospective Huntington at Risk Observational Study (PHAROS): implications for clinical trials
Genome-wide significance for a modifier of age at neurological onset in Huntington's disease at 6q23-24: the HD MAPS study
BMC Medical Genetics.
A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS study
American Journal of Human Genetics.
Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease
American Journal of Medical Genetics. Part A.
Map of science